These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35408711)

  • 1. Automated Computational Detection of Disease Activity in ANCA-Associated Glomerulonephritis Using Raman Spectroscopy: A Pilot Study.
    Morris AD; Freitas DLD; Lima KMG; Floyd L; Brady ME; Dhaygude AP; Rowbottom AW; Martin FL
    Molecules; 2022 Apr; 27(7):. PubMed ID: 35408711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative complement pathway activation products in urine and kidneys of patients with ANCA-associated GN.
    Gou SJ; Yuan J; Wang C; Zhao MH; Chen M
    Clin J Am Soc Nephrol; 2013 Nov; 8(11):1884-91. PubMed ID: 24115193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Histological Subtyping of Immune Cell Infiltrates in MPO-ANCA and PR3-ANCA Glomerulonephritis.
    Hakroush S; Tampe D; Ströbel P; Korsten P; Tampe B
    Front Immunol; 2021; 12():737708. PubMed ID: 34759920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of Renal Outcomes in Sclerotic Class Anti-Neutrophil Cytoplasmic Antibody Glomerulonephritis.
    Menez S; Hruskova Z; Scott J; Cormican S; Chen M; Salama AD; Alasfar S; Little MA; Safrankova H; Honsova E; Tesar V; Geetha D
    Am J Nephrol; 2018; 48(6):465-471. PubMed ID: 30472700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The transition of renal histopathology after immunosuppressive therapy in a woman with renal limited ANCA-associated vasculitis: a case report and literature review.
    Li XY; Liang YS; Pai P
    Clin Exp Rheumatol; 2016; 34(3 Suppl 97):S115-20. PubMed ID: 26841801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The level of urinary α1 microglobulin excretion is a useful marker of peritubular capillaritis in antineutrophil cytoplasmic antibody associated vasculitis.
    Ohashi N; Ishigaki S; Kitajima K; Tsuji N; Isobe S; Iwakura T; Ono M; Fujikura T; Tsuji T; Sakao Y; Kato A; Yasuda H
    Clin Exp Nephrol; 2015 Oct; 19(5):851-8. PubMed ID: 25528655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interstitial Immunostaining and Renal Outcomes in Antineutrophil Cytoplasmic Antibody-Associated Glomerulonephritis.
    Geetha D; Sethi S; De Vriese AS; Specks U; Kallenberg CGM; Lim N; Spiera R; St Clair EW; Merkel PA; Seo P; Monach PA; Lepori N; Fessler BJ; Langford CA; Hoffman GS; Sharma R; Stone JH; Fervenza FC;
    Am J Nephrol; 2017; 46(3):231-238. PubMed ID: 28881339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of a renal risk score in a cohort of children with ANCA-associated glomerulonephritis.
    Zhang P; Yao J; Gao CL; Fang X; Zhang ZQ; Xia ZK
    J Investig Med; 2023 Dec; 71(8):854-864. PubMed ID: 37615067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum and urinary metabolites discriminate disease activity in ANCA associated glomerulonephritis in a pilot study.
    Geetha D; Attarwala N; Zhang C; Kant S; Antiochos B; Seo P; Le A
    J Nephrol; 2022 Mar; 35(2):657-663. PubMed ID: 34181196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological analysis of ANCA-associated glomerulonephritis focusing on plasma cell infiltrate.
    Masuzawa N; Nishimura A; Mihara Y; Tamagaki K; Konishi E
    Clin Exp Nephrol; 2019 Dec; 23(12):1373-1381. PubMed ID: 31485791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of MPO-ANCA-mediated oxidative imbalance on renal vasculitis.
    Hilhorst M; Maria AT; Kavian N; Batteux F; Borderie D; Le Quellec A; van Paassen P; Guilpain P
    Am J Physiol Renal Physiol; 2018 Dec; 315(6):F1769-F1776. PubMed ID: 30207165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pathology of the ANCA-associated vasculitides].
    Ferrario F; Vanzati A; Pilla D; Pagni F
    G Ital Nefrol; 2013; 30(2):. PubMed ID: 23832458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary Soluble CD163 and Disease Activity in Biopsy-Proven ANCA-Associated Glomerulonephritis.
    Aendekerk JP; Timmermans SAMEG; Busch MH; Potjewijd J; Heeringa P; Damoiseaux JGMC; Reutelingsperger CP; van Paassen P;
    Clin J Am Soc Nephrol; 2020 Dec; 15(12):1740-1748. PubMed ID: 33203735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organisation of lymphocytic infiltrates in ANCA-associated glomerulonephritis.
    Brix SR; Noriega M; Herden EM; Goldmann B; Langbehn U; Busch M; Jabs WJ; Steinmetz OM; Panzer U; Huber TB; Stahl RAK; Wiech T
    Histopathology; 2018 Jun; 72(7):1093-1101. PubMed ID: 29453894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An index for renal outcome in ANCA-associated glomerulonephritis.
    Vergunst CE; van Gurp E; Hagen EC; van Houwelingen HC; Hauer HA; Noël LH; Waldherr R; Ferrario F; van der Woude FJ; Bruijn JA; Bajema IM;
    Am J Kidney Dis; 2003 Mar; 41(3):532-8. PubMed ID: 12612975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kidney biopsy chronicity grading in antineutrophil cytoplasmic antibody-associated vasculitis.
    Casal Moura M; Fervenza FC; Specks U; Sethi S
    Nephrol Dial Transplant; 2022 Aug; 37(9):1710-1721. PubMed ID: 34436585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pauci-immune glomerulonephritis: does negativity of anti-neutrophilic cytoplasmic antibodies matters?
    Sharma A; Nada R; Naidu GS; Minz RW; Kohli HS; Sakhuja V; Gupta KL; Rathi M
    Int J Rheum Dis; 2016 Jan; 19(1):74-81. PubMed ID: 26269223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. urinary biomarkers in relapsing antineutrophil cytoplasmic antibody-associated vasculitis.
    Lieberthal JG; Cuthbertson D; Carette S; Hoffman GS; Khalidi NA; Koening CL; Langford CA; Maksimowicz-McKinnon K; Seo P; Specks U; Ytterberg SR; Merkel PA; Monach PA;
    J Rheumatol; 2013 May; 40(5):674-83. PubMed ID: 23547217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal histology in pauci-immune rapidly progressive glomerulonephritis: 8-year retrospective study.
    Minz RW; Chhabra S; Joshi K; Rani L; Sharma N; Sakhuja V; Duggal R; Pasricha N
    Indian J Pathol Microbiol; 2012; 55(1):28-32. PubMed ID: 22499296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive Analysis of Sex Differences at Disease Manifestation in ANCA-Associated Glomerulonephritis.
    Tampe D; Korsten P; Ströbel P; Hakroush S; Tampe B
    Front Immunol; 2021; 12():736638. PubMed ID: 34630417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.